References
- Alving CR. (1991). Liposomes as carriers of antigens and adjuvants. J Immunol Methods, 140, 1–13.
- Ashley DM, Meier L, Kerby T, Zalduondo FM, Friedman HS, Gajjar A, Kun L, Duffner PK, Smith S, Longee D. (1996). Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol, 14, 1922–1927.
- Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, 238–252.
- Chamberlain MC. (1993). Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol, 15, 133–139.
- Fry DW, White JC, Goldman ID. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem, 90, 809–815.
- Gregoriadis G. (1990). Immunological adjuvants: a role for liposomes. Immunol Today, 11, 89–97.
- Gupta Y, Jain A, Jain SK. (2007). Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol, 59, 935–940.
- Hoare DG, Koshland DE. (1966). A procedure for the selective modification of carboxyl group in proteins. J Amer Chem Society, 88, 2057–2058.
- Lee CM, Tanaka T, Murai T, Kondo M, Kimura J, Su W, Kitagawa T, Ito T, Matsuda H, Miyasaka M. (2002). Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res, 62, 4282–4288.
- Leserman L. (2004). Liposomes as protein carriers in immunology. J Liposome Res, 14, 175–189.
- Maruyama K, Holmberg E, Kennel SJ, Klibanov A, Torchilin VP, Huang L. (1990). Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J Pharm Sci, 79, 978–984.
- Mishra PK, Gulbake A, Jain A, Vyas SP, Jain SK. (2009). Targeted delivery of an anti-cancer agent via steroid coupled liposomes. Drug Deliv, 16, 437–447.
- Muggia FM. (1997). Phase II study of liposomal doxuribicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J. Clin. Oncol, 15, 987–993.
- Northfeld DW. (1997). Liposomal anthracycline chemotherapy in the treatment of AIDS-related Kaposi’s salcoma. Oncology, 11, 21–31.
- Sneath RJ, Mangham DC. (1986). The normal structure and function of CD44 and its role in neoplasia. MP, Mol Pathol, 51, 191–200.
- Sorensen EN, Weisman G, Vidaver GA. (1977). A sephadex column procedure for measuring uptake and loss of low molecular weight solutes from small, lipid-rich vesicles. Anal Biochem, 82, 376–384.
- Takakura Y, Hashida M. (1986). Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res, 13, 820–831.